In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...
In the last three months, 11 analysts have published ratings on Confluent CFLT, offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...
Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...
As such, this is a guest post written by Peter Pugh-Jones, in his capacity as director of strategic accounts at Confluent. Understanding how the cadence and throughput of real-time data impacts ...
We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a ...
Confluent is a terrific "growth at a reasonable price" software stock that has only seen its share price rise ~20% over the past year, despite strong growth. Confluent, founded by creators of open ...
Morgan Stanley analyst Sanjit Singh downgraded the rating on Confluent (CFLT – Research Report) to a Hold today, setting a price target of $30.00. Discover outperforming stocks and invest ...
LOUISVILLE, Ky., Jan. 21, 2025 /PRNewswire/ -- Confluent Health today announced that it has promoted Dr. Stephen Clark, PT, DPT, OCS, ATC to the newly created role of Chief Clinical Officer (CCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback